Barclays CEO Venkat completes treatment for cancer, in remission
LONDON (Reuters) - British bank Barclays said on Friday that its chief executive C.S. Venkatakrishnan has completed treatment for non-Hodgkin lymphoma, a type of cancer, and is now in remission.
"I am pleased to inform you that I have completed the treatment for non-Hodgkin lymphoma that I commenced last November. I am now in remission (no evidence of disease)," Venkatakrishnan told colleagues in a letter, according to a company statement.
"Over the coming weeks, I plan to be working more from the office, and ultimately resuming travel."
The CEO, known inside the bank as Venkat, had previously said in November that doctors viewed his prognosis as "excellent" and that he would keep working when possible, while receiving treatment in New York.
"I am very grateful for the care I have received," he added in his letter.
"As always, I encourage you to pay close attention to your physical and mental wellbeing. If you or eligible members of your family have been diagnosed with cancer, please do make use of the support we provide to employees worldwide."
(Reporting by Iain Withers; editing by Jason Neely)